Prescriber Insights: APRN

Commentary: Opioids for Chronic Non-Cancer Pain January 2012

Article: You'll see ondansetron (Zofran, etc) join the list of drugs with stronger warnings about QT prolongation January 2012

Article: how to handle peripheral edema due to dihydropyridine calcium channel blockers (amlodipine, etc) September 2011

Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011

Commentary: New Drug: Xarelto (Rivaroxaban) August 2011

Article: new ORAL anticoagulant called Xarelto (zuh-REL-toe) August 2011

Article: Daliresp (DA-li-resp), a new oral tablet for severe COPD in patients with chronic bronchitis July 2011

Commentary: New Drug: Daliresp (Roflumilast) July 2011

Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2010) July 2011

Chart: Drug Regimens for Latent Tuberculosis (TB) February 2011

Guideline: Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain September 2010

Article: how to manage opioid therapy in patients with chronic non-cancer pain September 2010

Article: new black box warning for OxyContin (oxycodone) about interactions with CYP3A4 drugs June 2010

Article: QT prolongation drug interactions with some antipsychotics, antiarrhythmics, antibiotics April 2010

Article: Interaction alerts often pop up about possible serotonin syndrome when patients get more than one serotonergic drug October 2009

Neurology